H Ludlam, M Dryden, I Barton, I Phillips. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Bacterial Infections/drug therapyCiprofloxacin/administration & dosageCiprofloxacin/therapeutic useDrug Resistance, MicrobialHumansKidney Failure, Chronic/complicationsKidney Failure, Chronic/therapyPeritoneal Dialysis, Continuous AmbulatoryPeritonitis/drug therapyPeritonitis/etiology
Substances： See more » Ciprofloxacin
Year: 1990 PMID： 2211442 DOI： 10.1093/jac/26.1.162
Source DB: PubMed Journal: J Antimicrob Chemother ISSN： 0305-7453 Impact factor: 5.790